Update shared on 19 Nov 2025
Fair value Decreased 3.33%The analyst price target for Bioceres Crop Solutions was revised downward from $3.75 to $3.63. Analysts cited increased pressure from liquidity concerns and recent portfolio challenges as key factors for the adjustment.
Analyst Commentary
Recent street research reflects a range of opinions on Bioceres Crop Solutions. Analysts are weighing both the company's growth opportunities and its operational headwinds.
Bullish Takeaways- Bullish analysts see value in Bioceres' next-generation products and note their potential to contribute positively to the company's future portfolio performance.
- Despite weaker-than-expected financial results in Q4, some analysts believe FY25 could represent a low point for EBITDA. This could signal potential recovery afterward.
- The long-term outlook for the business remains positive due to innovation and the strength of core offerings, which could drive valuation improvement over time.
- Bearish analysts are concerned about increased volatility in Argentina. This has raised liquidity issues and created uncertainties in the firm's operating environment.
- Recent leadership changes, particularly the CFO's departure, have been flagged as a risk for smooth execution and management stability.
- Default notices from major stakeholders are viewed as significant impediments to ongoing recapitalization efforts and portfolio transformation plans.
- Overall, the challenging macroeconomic and company-specific circumstances have led to downward revisions in price targets and more cautious recommendations.
What's in the News
- Auditor PricewaterhouseCoopers LLP expressed doubt about Bioceres Crop Solutions' ability to continue as a going concern in the company's recently filed 20-F for the period ending June 30, 2025 (Key Developments).
- Bioceres Crop Solutions announced it will not meet the SEC deadline for its next 20-F filing, which raises questions about its financial reporting timelines (Key Developments).
- A strategic collaboration was established with the Colorado Wheat Research Foundation to develop and commercialize HB4 wheat in the United States. This partnership aims to improve wheat productivity and environmental sustainability through shared technology and open licensing (Key Developments).
- The company announced a CFO transition. Enrique Lopez Lecube is stepping down, and an interim arrangement is in place as the search for a new Chief Financial Officer begins (Key Developments).
Valuation Changes
- Consensus Analyst Price Target has fallen slightly from $3.75 to $3.63.
- Discount Rate has increased from 37.87% to 40.48%, indicating a higher risk premium applied in valuation models.
- Revenue Growth assumptions have risen from 6.3% to 8.0%.
- Net Profit Margin forecast has increased materially from 1.92% to 9.61%.
- Future P/E multiple has fallen significantly from 81.63x to 16.99x. This reflects revised expectations for company earnings and valuation.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.